�Mazal Plant Pharmaceuticals
is bridging the gap
between nature
and science to
develop healthier pharmaceutical
drugs�
is bridging the gap
between nature
and science to
develop healthier pharmaceutical
drugs�
News & Financials
2011
Second quarter- Mazal June 30th 2011 unaudited
First quarter- Mazal March 31th 2011 unaudited
2010
Year End - Mazal December 31th 2010 unaudited
Third quarter - Mazal September 30th 2010 unaudited
Second quarter- Mazal June 30th 2010 unaudited
First quarter- Mazal March 31st 2010 unaudited
2009
The company's star drug candidate is MAHDL a potential HDL drug.
Site by: Aaron Ovadia